SIT AND DELIVER
Oral Small Molecule Targeting of Cancer with Cantex' Stephen Marcus
Dr. Stephen Marcus boasts drug development experience across various routes of administration targeting varied therapeutic areas. Now as Cantex CEO, he leans on his background as an oncologist to drive his passion for effectively treating cancer while easing the patient e...
Oral Peptide Delivery with Protagonist Therapeutics' Dinesh Patel
To stab or to swallow? For treating conditions in the I&I (immunology and inflammation) space – think psoriasis, as one common example – some see the holy grail of delivery as moving from injectable to oral administration. In this inaugural episode of Sit ...
ABOUT SIT AND DELIVER
Created for stakeholders across the drug delivery landscape, from sponsor companies to regulatory agencies, Sit and Deliver offers timely insights from leading thinkers on drug delivery trends, movements, opportunities, and challenges.
MEET OUR HOST
On each episode of Sit and Deliver, Drug Delivery Leader Chief Editor Tom von Gunden frames a topic of interest and impact to drug delivery professionals and invites a guest commentator to “deliver” perspectives on that focused topic.